Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 26/04/2008

    Curetis AG - Compact weapon against tuberculosis

    In conjunction with reference laboratories of the World Health Organization WHO medtech company Curetis AG is developing new technologies and products that identify the pathogens of infectious diseases such as tuberculosis and their resistance. The solutions are impressive.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-compact-weapon-against-tuberculosis
  • Press release - 20/01/2008 Building of GATC Biotech AG in Konstanz

    LifeCodexx AG - Clarity within the genetic data jungle

    Constance based GATC Biotech founds the subsidiary company LifeCodexx AG. LifeCodexx is the first web-based information service for the storage and utilisation of biological and medical data from the analysis of genetic codes and protein codes in the EU.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/lifecodexx-ag-clarity-within-the-genetic-data-jungle
  • Article - 03/03/2016 Schematic showing how liquid biopsies can be used to analyse freely circulating (fc) DNA in the blood. The schematic shows the technique as applied to GIST (gastrointestinal stroma tumours).

    Liquid biopsies – beacons of hope for cancer diagnosis?

    Researchers around the world, including researchers from the Freiburg University Medical Center, are working on developing simple blood tests, so-called liquid biopsies, that can be used to obtain accurate information about tumour staging and the progress of therapy. An international liquid biopsy symposium was held in Freiburg in October 2015 and has produced valuable insights.

    https://www.gesundheitsindustrie-bw.de/en/article/news/liquid-biopsies-beacons-of-hope-for-cancer-diagnosis
  • Press release - 06/08/2020

    A bridge between artificial intelligence and the life sciences

    The great potential of artificial intelligence (AI) and machine learning for the life sciences – from basic research in biology to medical applications – has largely been neglected to date. A new research unit aims to support AI research in the life sciences and to forge international links with the activities in Heidelberg.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ellis-life-heidelberg-bridge-between-artificial-intelligence-and-life-sciences
  • Press release - 21/01/2008

    Micro-biolytics GmbH - Top spectroscopy technology for the pharmaceutical industry

    Micro-biolytics GmbH now based in the Esslingen-based Life Science Centre develops and produces microsystems solutions for bioanalytical issues. With the support of networks micro-biolytics is hoping to considerably expand its activities.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/micro-biolytics-gmbh-top-spectroscopy-technology-for-the-pharmaceutical-industry
  • Article - 12/03/2012 The drawing shows a cuboid structure containing a channel through which a red thread is being fed.

    Biological nanopores on chips for determining the properties of molecules

    Researchers led by Prof. Dr. Jan C. Behrends and Dr. Gerhard Baaken from the University of Freiburg have developed a chip the size of a fingertip containing biological nanopores that determine molecule mass with great precision. Developing this new system which is a combination of biological and micro-technical components involved a great deal of technical skill. The system has the same level of sensitivity as a chromatography device but is much…

    https://www.gesundheitsindustrie-bw.de/en/article/news/biological-nanopores-on-chips-for-determining-the-properties-of-molecules
  • Diagnostics - 29/01/2018 The schematic shows a continuum of lipoprotein particles or different size and their division into major classes and subclasses.

    New test for extended blood fat analysis

    Cholesterol is seen as the cause of atherosclerosis, a disease that can lead to heart attacks and strokes. However, it now seems that the way cholesterol is packaged may be even more important than high blood cholesterol levels. Nuclear magnetic resonance (NMR) spectroscopy now allows the high-throughput analysis of such lipid packages.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-test-for-extended-blood-fat-analysis
  • Article - 08/10/2012 18269_de.jpg

    The Heidelberg Institute of Human Genetics celebrates its 50th anniversary

    On the occasion of its 50th anniversary, the Institute of Human Genetics at the University Hospital of Heidelberg celebrates its major achievements in molecular genetic analyses, the diagnosis of hereditary diseases and tumour diseases as well as its research into the molecular causes of genetic defects. The largest institute of human genetics in Germany is also at the forefront of genetic counselling and debates on health policies and ethical…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-heidelberg-institute-of-human-genetics-celebrates-its-50th-anniversary
  • Article - 20/05/2008

    Hugo Hämmerle: At the crossroads between research and industry

    The NMI Natural and Medical Sciences Institute in Reutlingen is a role model for how research findings can be turned into financially sustainable products and services. Prof. Hugo Hämmerle has been a key figure in this success story for over 20 years. In February 2008 he took over as Managing Director of the institute.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hugo-haemmerle-at-the-crossroads-between-research-and-industry
  • Article - 20/09/2010 The photo shows a pipetting system above a multi-well cell culture plate placed on the microscope stage.<br /> <br />

    PROcellcare – a cell nanny enters the market

    The idea and the first laboratory device were developed in Heidelberg at the European Molecular Biology Laboratory EMBL one of the worlds top-class research institutions before being turned into a product by the Heiligkreuzsteinach-based company PROdesign. PROcellcare a fully automated cell analysis and nutrient supply system that can be integrated into microscope is an impressive demonstration that innovation very much depends on the right…

    https://www.gesundheitsindustrie-bw.de/en/article/news/procellcare-a-cell-nanny-enters-the-market
  • Article - 19/03/2012 16674_de.jpg

    Protein aggregation: when proximity becomes dangerous

    The aggregation of proteins in the human body might have severe medical consequences, as is the case with Alzheimer’s disease, for example. A less known fact is that the biopharmaceutical industry is also faced with the biological phenomenon of protein aggregation and is working on preventive measures.

    https://www.gesundheitsindustrie-bw.de/en/article/news/protein-aggregation-when-proximity-becomes-dangerous
  • Article - 30/11/2015 The figure shows a model of the active centre of MccA.

    Bacterial MccA is better than other enzymes when it comes to reducing sulphites

    Dr. Bianca Hermann from the University of Freiburg specialises in multi-haem enzymes, and investigates the enzymes’ structure and reaction mechanisms. She has clarified the enzymes’ crystal structure and reaction mechanisms and found out why the bacterial MccA enzyme complex can reduce sulphur-containing substances such as sulphites up to a hundred times faster than other enzymes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bacterial-mcca-is-better-than-other-enzymes-when-it-comes-to-reducing-sulphites
  • Article - 01/03/2017 Team of developers from the Fraunhofer ICT (from left to right: Martin Joos, Matthias Stier,
Stephan Scherle) in front of the foxySpec system. Photo taken at ACHEMA 2016.

    foxySpec – an analysis system with huge potential for bioproduction and diagnostics

    The mass spectrometry-based foxySpec system enables the monitoring of gases and liquids simultaneously in real time. These simultaneous measurements make the system interesting for medical diagnostics applications. However, bioproduction can also benefit from foxySpec, which can also be used to measure a large number of products during the production process in real time, thus supporting smooth processes in fermenters.

    https://www.gesundheitsindustrie-bw.de/en/article/news/foxyspec-an-analysis-system-with-huge-potential-for-bioproduction-and-diagnostics
  • Article - 20/12/2007

    Viruses are the major cause of myocardial diseases

    About 500000 people in Germany suffer from dilatative cardiomyopathy DCM. Viral infections are the major cause of this myocardial disease. Its molecular and cellular mechanisms are being investigated in a transregional SFB project at the University of Tübingen.

    https://www.gesundheitsindustrie-bw.de/en/article/news/viruses-are-the-major-cause-of-myocardial-diseases
  • Article - 10/02/2008 DAccepted the invitation to come to Reutlingen and talk about biomarkers (from left to right) - Mike Spain, Hanno Langen, Thomas Caskey, Larry Gold, Oliver Poetz, Thomas Joos und Hans Berger (Photo: NMI)

    4th Biomarker Workshop at the NMI in Reutlingen: another success

    The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130 this years workshop exceeded all previous ones. Those who were keen to find out more about the latest trends and findings were presented with a successful mix of basic and applied research information.

    https://www.gesundheitsindustrie-bw.de/en/article/news/4th-biomarker-workshop-at-the-nmi-in-reutlingen-another-success
  • Dossier - 05/10/2011 15491_de.jpg

    Biosimilars: follow-on biologics of innovator biopharmaceutical products

    As blockbuster biopharmaceuticals go off patent, biosimilars are increasingly competing with them for a market share. However, the production of biosimilars is rather complex and costly. The approval of biosimilars is also subject to many hurdles. Their introduction to the very expensive biopharmaceuticals market is often associated with marginal price reductions.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/biosimilars-follow-on-biologics-of-innovator-biopharmaceutical-products
  • Press release - 18/11/2021

    Overcoming resistance to treatment for breast, bowel, and pancreatic cancer

    As cancer progresses, the tumor cells continually change, ultimately resulting in a tumor consisting of a large number of different cell clones with different characteristics. This is referred to as "tumor heterogeneity". In many cases, the cancer cells become resistant to the treatments available.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/overcoming-resistance-treatment-breast-bowel-and-pancreatic-cancer
  • Article - 18/05/2017 The photo shows a pipette with which drinking water is applied to the ImmuStick.

    ImmuStick – novel rapid test for identifying disease pathogens

    In some situations such as in the food and pharmaceutical industries or hospitals, a test to identify disease pathogens can be vital. At present, such tests are relatively time-consuming and can take hours or even days to produce results, depending on the pathogen. Scientists from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart are currently developing a rapid test called ImmuStick which is as easy to use…

    https://www.gesundheitsindustrie-bw.de/en/article/news/immustick-novel-rapid-test-for-identifying-disease-pathogens
  • Article - 22/10/2012 The photo shows the hand of a patient with open lesions.<br />

    The crème de la crème of contact allergy tests goes in vitro

    As of 2013 all cosmetic products containing a chemical with inherent skin sensitisation potential must be tested without the traditional animal testing. Prof. Dr. Stefan Martin from the Department of Dermatology at the University of Freiburg Medical Centre and his partners have been looking for alternatives to animal testing and have come up with the most specific in vitro test there has ever been. The researchers involved in the project have…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-cr-me-de-la-cr-me-of-contact-allergy-tests-goes-in-vitro
  • Article - 14/08/2018 Photo of the developer team (from left to right): Jonas Pfeil, Daniel
Geiger and Tobias Neckernuß. An optical measurement system can be seen on the right-hand side. Photo: Daniel Geiger

    Simple and fast: new optical method for analysing living cells

    The junior researchers Dr. Daniel Geiger, Tobias Neckernuß and Jonas Pfeil from Ulm have developed an innovative method for non-contact real-time analysis of cells and other particles. The analysis involves low data rates and correspondingly little effort. This is what makes the method so attractive for medical applications.

    https://www.gesundheitsindustrie-bw.de/en/article/news/simple-and-fast-new-optical-method-for-analysing-living-cells
  • Press release - 07/12/2020

    One for all

    AI-based evaluation of medical imaging data usually requires a specially developed algorithm for each task. Scientists from the German Cancer Research Center (DKFZ) have now presented a new method for configuring self-learning algorithms for a large number of different imaging datasets – without the need for specialist knowledge or very significant computing power.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/one-all
  • Article - 15/04/2013 19462_de.jpg

    Molecule-specific diagnosis of metabolic diseases

    In cooperation with the company Centogene AG Prof. Dr. Michael Przybylski from the Steinbeis Transfer Center for Biopolymer Analysis and Biomolecular Mass Spectrometry at the University of Konstanz has developed a method that involves a novel substance class and enables the parallel measurement of enzyme activity based on fluorometry and mass spectroscopy. The method for which the inventors have recently filed a patent application forms the basis…

    https://www.gesundheitsindustrie-bw.de/en/article/news/molecule-specific-diagnosis-of-metabolic-diseases
  • Expert interview - 16/01/2019 Photo of Holger Mettler

    Cybersecurity is an important issue for the pharmaceutical industry

    In an increasingly interconnected world, the pharmaceutical and biotechnology sectors need to be aware of cybersecurity threats in manufacturing. We talked about these threats with Holger Mettler who is in charge of computer system validation and cybersecurity at Exyte (formerly M + W), a global enterprise that designs, engineers and constructs complex manufacturing facilities and buildings for the life sciences industry.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cybersecurity-is-an-important-issue-for-the-pharmaceutical-industry
  • Dossier - 14/11/2011 15755_de.jpg

    The European Nutrition and Health Claims Regulation - an interesting recipe

    The EU Nutrition and Health Claims Regulation applies to all nutrition and health claims made in commercial communications, including the advertising and labelling of food and promotional campaigns. While the information related to nutrition is now clear, the list of permitted health claims is still under development.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-european-nutrition-and-health-claims-regulation-an-interesting-recipe
  • Article - 30/06/2008

    Safety is paramount

    The new drug screening and safety pharmacology laboratory at NMI Technologie Transfer GmbH NMI TT GmbH in Reutlingen with its standardised and special test systems complies fully with the requirements of safety pharmacology tests.

    https://www.gesundheitsindustrie-bw.de/en/article/news/safety-is-paramount

Page 5 / 7

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search